Subchondral and intra-articular injections of bone marrow concentrate are a safe and effective treatment for knee osteoarthritis: a prospective, multi-center pilot study.
BMAC
Bone marrow
Injective
Intra-articular
Knee
Osteoarthritis
Subchondral
Journal
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
ISSN: 1433-7347
Titre abrégé: Knee Surg Sports Traumatol Arthrosc
Pays: Germany
ID NLM: 9314730
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
13
11
2020
accepted:
04
03
2021
pubmed:
28
3
2021
medline:
19
11
2021
entrez:
27
3
2021
Statut:
ppublish
Résumé
Subchondral bone is becoming a treatment target for knee OA patients, with promising early findings on the use of bone marrow aspirate concentrate (BMAC). The aim of this prospective, multi-centric pilot study was to evaluate safety as well as clinical and MRI outcomes of a combined approach of intra-articular and subchondral BMAC injections. Thirty patients (19 men, 11 women, 56.4 ± 8.1 years) with symptomatic knee OA were treated with a combination of an intra-articular and two subchondral BMAC injections (femoral condyle and tibial plateau). Patients were evaluated at baseline and at 1-3-6-12 months of follow-up with the IKDC subjective, VAS, KOOS, and EQ-VAS scores. The MRI evaluation was performed with the WORMS score. No major complications were reported and only two patients were considered treatment failures, requiring a new injective or surgical treatment. The IKDC subjective score improved significantly from 40.5 ± 12.5 to 59.9 ± 16.1 at 3 months, 59.1 ± 12.2 at 6 months, and 62.6 ± 19.4 at 12 months (p < 0.0005). A similar improvement was reported for VAS pain and all KOOS subscales at all follow-ups, while EQ-VAS did not show any significant improvement. The MRI analysis showed a significant bone marrow edema reduction (p = 0.003), while the remaining WORMS parameters did not show any significant changes. The pilot evaluation of this combined BMAC injective treatment showed safety and positive outcome up to 12 months of follow-up in patients with symptomatic knee OA associated with subchondral bone alterations. These findings suggest that targeting both subchondral bone and joint environment can provide promising results, and that BMAC can be a valid option for this combined approach to treat knee OA.
Identifiants
pubmed: 33772602
doi: 10.1007/s00167-021-06530-x
pii: 10.1007/s00167-021-06530-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4232-4240Informations de copyright
© 2021. European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA).
Références
Altamura SA, Di Martino A, Andriolo L, Boffa A, Zaffagnini S, Cenacchi A et al (2020) Platelet-Rich Plasma for sport-active patients with knee osteoarthritis: limited return to sport. Biomed Res Int 2020:8243865
doi: 10.1155/2020/8243865
Angadi DS, Edwards D, Melton JTK (2020) Calcium phosphate injection of symptomatic bone marrow lesions of the knee: what is the current clinical evidence? Knee Surg Relat Res 32:4
doi: 10.1186/s43019-019-0013-3
Astur DC, de Freitas EV, Cabral PB, Morais CC, Pavei BS, Kaleka CC et al (2019) Evaluation and management of subchondral calcium phosphate injection technique to treat bone marrow lesion. Cartilage 10:395–401
doi: 10.1177/1947603518770249
Bayliss LE, Culliford D, Monk AP, Glyn-Jones S, Prieto-Alhambra D, Judge A et al (2017) The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Lancet 389:1424–1430
doi: 10.1016/S0140-6736(17)30059-4
Blumenkrantz G, Lindsey CT, Dunn TC, Jin H, Ries MD, Link TM et al (2004) A pilot, two-year longitudinal study of the interrelationship between trabecular bone and articular cartilage in the osteoarthritic knee. Osteoarthr Cartil 12:997–1005
doi: 10.1016/j.joca.2004.09.001
Cassano JM, Kennedy JG, Ross KA, Fraser EJ, Goodale MB, Fortier LA (2018) Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration. Knee Surg Sports Traumatol Arthrosc 26:333–342
doi: 10.1007/s00167-016-3981-9
Cavallo C, Boffa A, Andriolo L, Silva S, Grigolo B, Zaffagnini S et al (2020) Bone marrow concentrate injections for the treatment of osteoarthritis: evidence from preclinical findings to the clinical application. Int Orthop. https://doi.org/10.1007/s00264-020-04703-w
doi: 10.1007/s00264-020-04703-w
pubmed: 32661635
Cohen SB, Sharkey PF (2016) Subchondroplasty for treating bone marrow lesions. J Knee Surg 29:555–563
pubmed: 26641077
Cohen SB, Sharkey PF (2012) Surgical treatment of osteoarthritis pain related to subchondral bone defects or bone marrow lesions: subchondroplasty. Tech Knee Surg 11(4):170–175
doi: 10.1097/BTK.0b013e318276e1fe
Delgado D, Garate A, Vincent H, Bilbao AM, Patel R, Fiz N et al (2019) Current concepts in intraosseous Platelet-Rich Plasma injections for knee osteoarthritis. J Clin Orthop Trauma 10:36–41
doi: 10.1016/j.jcot.2018.09.017
Di Matteo B, Polignano A, Onorato F, La Porta A, Iacono F, Bonanzinga T et al (2020) Knee intraosseous injections: a systematic review of clinical evidence of different treatment alternatives. Cartilage. https://doi.org/10.1177/19476035209594031947603520959403
doi: 10.1177/19476035209594031947603520959403
pubmed: 32959675
Di Matteo B, Vandenbulcke F, Vitale ND, Iacono F, Ashmore K, Marcacci M et al (2019) Minimally manipulated mesenchymal stem cells for the treatment of knee osteoarthritis: a systematic review of clinical evidence. Stem Cells Int 2019:1735242
doi: 10.1155/2019/1735242
Felson DT, Chaisson CE, Hill CL, Totterman SM, Gale ME, Skinner KM et al (2001) The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 134:541–549
doi: 10.7326/0003-4819-134-7-200104030-00007
Filardo G, Kon E, Longo UG, Madry H, Marchettini P, Marmotti A et al (2016) Non-surgical treatments for the management of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc 24:1775–1785
doi: 10.1007/s00167-016-4089-y
Filardo G, Madry H, Jelic M, Roffi A, Cucchiarini M, Kon E (2013) Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc 21:1717–1729
doi: 10.1007/s00167-012-2329-3
Filardo G, Previtali D, Napoli F, Candrian C, Zaffagnini S, Grassi A (2020) PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Cartilage. https://doi.org/10.1177/19476035209311701947603520931170
doi: 10.1177/19476035209311701947603520931170
pubmed: 33356491
Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ (2011) The role of growth factors in cartilage repair. Clin Orthop Relat Res 469:2706–2715
doi: 10.1007/s11999-011-1857-3
Fortier LA, Potter HG, Rickey EJ, Schnabel LV, Foo LF, Chong LR et al (2010) Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Jt Surg Am 92:1927–1937
doi: 10.2106/JBJS.I.01284
Fortier LA, Strauss EJ, Shepard DO, Becktell L, Kennedy JG (2019) Biological effects of bone marrow concentrate in knee pathologies. J Knee Surg 32:2–8
doi: 10.1055/s-0038-1676069
Gaul F, Bugbee WD, Hoenecke HR Jr, D’Lima DD (2019) A review of commercially available point-of-care devices to concentrate bone marrow for the treatment of osteoarthritis and focal cartilage lesions. Cartilage 10:387–394
doi: 10.1177/1947603518768080
Hernigou P, Auregan JC, Dubory A, Flouzat-Lachaniette CH, Chevallier N, Rouard H (2018) Subchondral stem cell therapy versus contralateral total knee arthroplasty for osteoarthritis following secondary osteonecrosis of the knee. Int Orthop 42:2563–2571
doi: 10.1007/s00264-018-3916-9
Hernigou P, Bouthors C, Bastard C, Flouzat Lachaniette CH, Rouard H, Dubory A (2020) Subchondral bone or intra-articular injection of bone marrow concentrate mesenchymal stem cells in bilateral knee osteoarthritis: what better postpone knee arthroplasty at fifteen years? Int Orthop, A randomized study. https://doi.org/10.1007/s00264-020-04687-7
doi: 10.1007/s00264-020-04687-7
Hernigou P, Delambre J, Quiennec S, Poignard A (2020) Human bone marrow mesenchymal stem cell injection in subchondral lesions of knee osteoarthritis: a prospective randomized study versus contralateral arthroplasty at a mean fifteen year follow-up. Int Orthop. https://doi.org/10.1007/s00264-020-04571-4
doi: 10.1007/s00264-020-04571-4
pubmed: 33037446
Hernigou P, Poignard A, Beaujean F, Rouard H (2005) Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87:1430–1437
pubmed: 15995108
Imhof H, Sulzbacher I, Grampp S, Czerny C, Youssefzadeh S, Kainberger F (2000) Subchondral bone and cartilage disease: a rediscovered functional unit. Invest Radiol 35:581–588
doi: 10.1097/00004424-200010000-00004
Kim IJ, Kim DH, Jung JY, Song YW, Guermazi A, Crema MD et al (2013) Association between bone marrow lesions detected by magnetic resonance imaging and knee pain in community residents in Korea. Osteoarthr Cartil 21:1207–1213
doi: 10.1016/j.joca.2013.05.001
Kwan Tat S, Lajeunesse D, Pelletier JP, Martel-Pelletier J (2010) Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Pract Res Clin Rheumatol 24:51–70
doi: 10.1016/j.berh.2009.08.004
Lopa S, Colombini A, Moretti M, de Girolamo L (2019) Injective mesenchymal stem cell-based treatments for knee osteoarthritis: from mechanisms of action to current clinical evidences. Knee Surg Sports Traumatol Arthrosc 27:2003–2020
doi: 10.1007/s00167-018-5118-9
Lychagin A, Lipina M, Garkavi A, Islaieh O, Timashev P, Ashmore K et al (2020) Intraosseous injections of platelet rich plasma for knee bone marrow lesions treatment: one year follow-up. Int Orthop. https://doi.org/10.1007/s00264-020-04546-5
doi: 10.1007/s00264-020-04546-5
pubmed: 32300831
Mobasheri A, Batt M (2016) An update on the pathophysiology of osteoarthritis. Ann Phys Rehabil Med 59:333–339
doi: 10.1016/j.rehab.2016.07.004
Pan J, Wang B, Li W, Zhou X, Scherr T, Yang Y et al (2012) Elevated cross-talk between subchondral bone and cartilage in osteoarthritic joints. Bone 51:212–217
doi: 10.1016/j.bone.2011.11.030
Previtali D, Merli G, Di Laura FG, Candrian C, Zaffagnini S, Filardo G (2020) The long-lasting effects of “placebo injections” in knee osteoarthritis: a meta-analysis. Cartilage. https://doi.org/10.1177/19476035209065971947603520906597
doi: 10.1177/19476035209065971947603520906597
pubmed: 32551947
Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Abram F, Choquette D, Haraoui B et al (2008) Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. Ann Rheum Dis 67:683–688
doi: 10.1136/ard.2007.073023
Roffi A, Nakamura N, Sanchez M, Cucchiarini M, Filardo G (2018) Injectable systems for intra-articular delivery of mesenchymal stromal cells for cartilage treatment: A systematic review of preclinical and clinical evidence. Int J Mol Sci 19(11):3322. https://doi.org/10.3390/ijms19113322
doi: 10.3390/ijms19113322
pmcid: 6274908
Sanchez M, Anitua E, Delgado D, Sanchez P, Prado R, Goiriena JJ et al (2016) A new strategy to tackle severe knee osteoarthritis: Combination of intra-articular and intraosseous injections of Platelet Rich Plasma. Expert Opin Biol Ther 16:627–643
doi: 10.1517/14712598.2016.1157162
Sanchez M, Delgado D, Pompei O, Perez JC, Sanchez P, Garate A et al (2019) Treating severe knee osteoarthritis with combination of intra-osseous and intra-articular infiltrations of Platelet-Rich Plasma: an observational study. Cartilage 10:245–253
doi: 10.1177/1947603518756462
Sanchez M, Delgado D, Sanchez P, Muinos-Lopez E, Paiva B, Granero-Molto F et al (2016) Combination of intra-articular and intraosseous injections of Platelet Rich Plasma for severe knee osteoarthritis: a pilot study. Biomed Res Int 2016:4868613
doi: 10.1155/2016/4868613
Schweinberger MH, Roukis TS (2007) Percutaneous autologous bone marrow harvest from the calcaneus and proximal tibia: surgical technique. J Foot Ankle Surg 46:411–414
doi: 10.1053/j.jfas.2007.05.009
Sharma AR, Jagga S, Lee SS, Nam JS (2013) Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis. Int J Mol Sci 14:19805–19830
doi: 10.3390/ijms141019805
Singh V, Oliashirazi A, Tan T, Fayyad A, Shahi A (2019) Clinical and pathophysiologic significance of MRI identified bone marrow lesions associated with knee osteoarthritis. Arch Bone Jt Surg 7:211–219
pubmed: 31312677
pmcid: 6578476
Sundaram K, Vargas-Hernandez JS, Sanchez TR, Moreu NM, Mont MA, Higuera CA et al (2019) Are subchondral intraosseous injections effective and safe for the treatment of knee osteoarthritis? A systematic review. J Knee Surg 32:1046–1057
doi: 10.1055/s-0039-1677792
Vad V, Barve R, Linnell E, Harrison J (2016) Knee osteoarthritis treated with percutaneous chondral-bone interface optimization: a pilot trial. Surg Sci 07(01):1–12
doi: 10.4236/ss.2016.71001
Yusuf E, Kortekaas MC, Watt I, Huizinga TW, Kloppenburg M (2011) Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Ann Rheum Dis 70:60–67
doi: 10.1136/ard.2010.131904